ION BEAM APPLICATIONS (IBAB.BR) Fundamental Analysis & Valuation

EBR:IBAB • BE0003766806

Current stock price

13.78 EUR
-0.32 (-2.27%)
Last:

This IBAB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. IBAB.BR Profitability Analysis

1.1 Basic Checks

  • IBAB had positive earnings in the past year.
  • In the past year IBAB had a positive cash flow from operations.
  • Of the past 5 years IBAB 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
IBAB.BR Yearly Net Income VS EBIT VS OCF VS FCFIBAB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • IBAB's Return On Assets of 2.71% is in line compared to the rest of the industry. IBAB outperforms 40.98% of its industry peers.
  • IBAB has a Return On Equity of 14.29%. This is amongst the best in the industry. IBAB outperforms 81.97% of its industry peers.
  • IBAB's Return On Invested Capital of 16.28% is amongst the best of the industry. IBAB outperforms 93.44% of its industry peers.
Industry RankSector Rank
ROA 2.71%
ROE 14.29%
ROIC 16.28%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBAB.BR Yearly ROA, ROE, ROICIBAB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • With a Profit Margin value of 2.85%, IBAB is not doing good in the industry: 62.30% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of IBAB has declined.
  • IBAB's Operating Margin of 6.48% is in line compared to the rest of the industry. IBAB outperforms 42.62% of its industry peers.
  • In the last couple of years the Operating Margin of IBAB has declined.
  • IBAB's Gross Margin of 31.21% is on the low side compared to the rest of the industry. IBAB is outperformed by 83.61% of its industry peers.
  • IBAB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.48%
PM (TTM) 2.85%
GM 31.21%
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
IBAB.BR Yearly Profit, Operating, Gross MarginsIBAB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. IBAB.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBAB is creating value.
  • There is no outstanding debt for IBAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IBAB.BR Yearly Shares OutstandingIBAB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
IBAB.BR Yearly Total Debt VS Total AssetsIBAB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.72, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
  • IBAB's Altman-Z score of 1.72 is on the low side compared to the rest of the industry. IBAB is outperformed by 67.21% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
  • IBAB has a Debt to Equity ratio of 0.23. This is in the better half of the industry: IBAB outperforms 63.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACC2.04
WACC7.98%
IBAB.BR Yearly LT Debt VS Equity VS FCFIBAB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.94, IBAB is not doing good in the industry: 83.61% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
  • IBAB's Quick ratio of 0.62 is on the low side compared to the rest of the industry. IBAB is outperformed by 80.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.62
IBAB.BR Yearly Current Assets VS Current LiabilitesIBAB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IBAB.BR Growth Analysis

3.1 Past

  • IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.86%, which is quite impressive.
  • IBAB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.73% yearly.
  • The Revenue has grown by 21.86% in the past year. This is a very strong growth!
  • Measured over the past years, IBAB shows a quite strong growth in Revenue. The Revenue has been growing by 14.73% on average per year.
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%

3.2 Future

  • IBAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.60% yearly.
  • The Revenue is expected to decrease by -0.86% on average over the next years.
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IBAB.BR Yearly Revenue VS EstimatesIBAB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
IBAB.BR Yearly EPS VS EstimatesIBAB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. IBAB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 32.05 indicates a quite expensive valuation of IBAB.
  • IBAB's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of IBAB to the average of the S&P500 Index (27.42), we can say IBAB is valued inline with the index average.
  • The Price/Forward Earnings ratio is 13.31, which indicates a correct valuation of IBAB.
  • IBAB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IBAB is cheaper than 78.69% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, IBAB is valued a bit cheaper.
Industry RankSector Rank
PE 32.05
Fwd PE 13.31
IBAB.BR Price Earnings VS Forward Price EarningsIBAB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • IBAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBAB is cheaper than 81.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.48
IBAB.BR Per share dataIBAB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IBAB's earnings are expected to grow with 35.60% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y38.16%
EPS Next 3Y35.6%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. IBAB.BR Dividend Analysis

5.1 Amount

  • IBAB has a Yearly Dividend Yield of 1.24%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.26, IBAB pays a bit more dividend than its industry peers.
  • Compared to the average S&P500 Dividend Yield of 1.81, IBAB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IBAB.BR Yearly Dividends per shareIBAB.BR Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • IBAB pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
IBAB.BR Yearly Income VS Free CF VS DividendIBAB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M
IBAB.BR Dividend Payout.IBAB.BR Dividend Payout, showing the Payout Ratio.IBAB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IBAB.BR Fundamentals: All Metrics, Ratios and Statistics

ION BEAM APPLICATIONS

EBR:IBAB (4/24/2026, 7:00:00 PM)

13.78

-0.32 (-2.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27
Earnings (Next)05-09
Inst Owners27.34%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap417.26M
Revenue(TTM)620.22M
Net Income(TTM)17.00M
Analysts80
Price Target16.07 (16.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.28%
PT rev (3m)3.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 32.05
Fwd PE 13.31
P/S 0.7
P/FCF N/A
P/OCF 149.88
P/B 3.51
P/tB 4.42
EV/EBITDA 9.48
EPS(TTM)0.43
EY3.12%
EPS(NY)1.04
Fwd EY7.51%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.67%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.41
PEG (5Y)N/A
Graham Number6.16565 (-55.26%)
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 14.29%
ROCE 25.19%
ROIC 16.28%
ROICexc 17.24%
ROICexgc 20.74%
OM 6.48%
PM (TTM) 2.85%
GM 31.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 65.94%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 5.44%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.62
Altman-Z 1.72
F-Score6
WACC7.98%
ROIC/WACC2.04
Cap/Depr(3y)87.67%
Cap/Depr(5y)76.45%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%
EBIT growth 1Y38.72%
EBIT growth 3Y40.44%
EBIT growth 5Y-7.05%
EBIT Next Year88.61%
EBIT Next 3Y37.43%
EBIT Next 5YN/A
FCF growth 1Y85.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.43%
OCF growth 3YN/A
OCF growth 5YN/A

ION BEAM APPLICATIONS / IBAB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?

ChartMill assigns a fundamental rating of 3 / 10 to IBAB.BR.


What is the valuation status of ION BEAM APPLICATIONS (IBAB.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for ION BEAM APPLICATIONS?

ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ION BEAM APPLICATIONS?

The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 78.85% in the next year.


How sustainable is the dividend of ION BEAM APPLICATIONS (IBAB.BR) stock?

The dividend rating of ION BEAM APPLICATIONS (IBAB.BR) is 3 / 10 and the dividend payout ratio is 8.05%.